Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) Families.

Yang KY, Caughey AB, Little SE, Cheung MK, Chen LM.

Fam Cancer. 2011 Sep;10(3):535-43. doi: 10.1007/s10689-011-9444-z.

PMID:
21538078
2.

Cost-effectiveness analysis of prevention strategies for gynecologic cancers in Lynch syndrome.

Kwon JS, Sun CC, Peterson SK, White KG, Daniels MS, Boyd-Rogers SG, Lu KH.

Cancer. 2008 Jul 15;113(2):326-35. doi: 10.1002/cncr.23554.

3.

Gynecologic cancer prevention in Lynch syndrome/hereditary nonpolyposis colorectal cancer families.

Chen LM, Yang KY, Little SE, Cheung MK, Caughey AB.

Obstet Gynecol. 2007 Jul;110(1):18-25.

PMID:
17601891
4.

Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis.

Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA.

Ann Intern Med. 2011 Jul 19;155(2):69-79. doi: 10.7326/0003-4819-155-2-201107190-00002.

5.

A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.

Snowsill T, Huxley N, Hoyle M, Jones-Hughes T, Coelho H, Cooper C, Frayling I, Hyde C.

BMC Cancer. 2015 Apr 25;15:313. doi: 10.1186/s12885-015-1254-5.

6.

Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.

Schmeler KM, Lynch HT, Chen LM, Munsell MF, Soliman PT, Clark MB, Daniels MS, White KG, Boyd-Rogers SG, Conrad PG, Yang KY, Rubin MM, Sun CC, Slomovitz BM, Gershenson DM, Lu KH.

N Engl J Med. 2006 Jan 19;354(3):261-9.

7.

Gynecologic cancers associated with Lynch syndrome/HNPCC.

Schmeler KM, Lu KH.

Clin Transl Oncol. 2008 Jun;10(6):313-7. Review.

PMID:
18558577
8.

Prevalence of occult gynecologic malignancy at the time of risk reducing and nonprophylactic surgery in patients with Lynch syndrome.

Lachiewicz MP, Kravochuck SE, O'Malley MM, Heald B, Church JM, Kalady MF, Drake RD.

Gynecol Oncol. 2014 Feb;132(2):434-7. doi: 10.1016/j.ygyno.2013.10.033. Epub 2013 Nov 5.

PMID:
24211399
10.

The gynecological surveillance of women with Lynch syndrome in Sweden.

Tzortzatos G, Andersson E, Soller M, Askmalm MS, Zagoras T, Georgii-Hemming P, Lindblom A, Tham E, Mints M.

Gynecol Oncol. 2015 Sep;138(3):717-22. doi: 10.1016/j.ygyno.2015.07.016. Epub 2015 Jul 12.

PMID:
26177554
11.

Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance.

Brown GJ, St John DJ, Macrae FA, Aittomäki K.

Gynecol Oncol. 2001 Mar;80(3):346-9.

PMID:
11263929
12.

Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testing.

Manchanda R, Legood R, Burnell M, McGuire A, Raikou M, Loggenberg K, Wardle J, Sanderson S, Gessler S, Side L, Balogun N, Desai R, Kumar A, Dorkins H, Wallis Y, Chapman C, Taylor R, Jacobs C, Tomlinson I, Beller U, Menon U, Jacobs I.

J Natl Cancer Inst. 2014 Nov 30;107(1):380. doi: 10.1093/jnci/dju380. Print 2015 Jan.

13.

Cost-effectiveness of microsatellite instability screening as a method for detecting hereditary nonpolyposis colorectal cancer.

Ramsey SD, Clarke L, Etzioni R, Higashi M, Berry K, Urban N.

Ann Intern Med. 2001 Oct 16;135(8 Pt 1):577-88.

PMID:
11601929
14.

A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.

Snowsill T, Huxley N, Hoyle M, Jones-Hughes T, Coelho H, Cooper C, Frayling I, Hyde C.

Health Technol Assess. 2014 Sep;18(58):1-406. doi: 10.3310/hta18580. Review.

15.

Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome.

Wang G, Kuppermann M, Kim B, Phillips KA, Ladabaum U.

Am J Manag Care. 2012 May 1;18(5):e179-85.

16.

Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.

Lancaster JM, Powell CB, Kauff ND, Cass I, Chen LM, Lu KH, Mutch DG, Berchuck A, Karlan BY, Herzog TJ; Society of Gynecologic Oncologists Education Committee.

Gynecol Oncol. 2007 Nov;107(2):159-62.

PMID:
17950381
17.

Genetic predisposition in gynecologic cancers.

Daniels MS, Lu KH.

Semin Oncol. 2016 Oct;43(5):543-547. doi: 10.1053/j.seminoncol.2016.08.005. Epub 2016 Sep 20. Review.

PMID:
27899185
18.

Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome.

Gerritzen LH, Hoogerbrugge N, Oei AL, Nagengast FM, van Ham MA, Massuger LF, de Hullu JA.

Fam Cancer. 2009;8(4):391-7. doi: 10.1007/s10689-009-9252-x. Epub 2009 Jun 6.

19.

Chemoprevention of colorectal cancer: systematic review and economic evaluation.

Cooper K, Squires H, Carroll C, Papaioannou D, Booth A, Logan RF, Maguire C, Hind D, Tappenden P.

Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320. Review.

20.

Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.

Manchanda R, Menon U, Michaelson-Cohen R, Beller U, Jacobs I.

Curr Opin Obstet Gynecol. 2009 Feb;21(1):31-8. doi: 10.1097/GCO.0b013e32831c844d. Review.

PMID:
19125001

Supplemental Content

Support Center